Year: 2023
Type: other
Abstract: Assessment of lapatinib or trametinib as OATP1B1 substrates. (A) Percent uptake of 3H-lapatinib (1 µM) in OATP1B1 overexpressing HEK293 cells relative to uptake in HEK293 cells transfected with a vector control (VC) (n=3, from a single experiment). (B) Lineweaver-Burke plot for OATP1B1-dependent uptake in HEK293-OATP1B1 cells treated with various concentrations of trametinib (0 - 5 µM) and 8FcA (0 - 40 µM) (n=9, and a combination of 3 independent experiments) . * denotes P < 0.001 vs VC. All values represent mean {plus minus} SEM.
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361890308
